<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03431740</url>
  </required_header>
  <id_info>
    <org_study_id>2017-01374</org_study_id>
    <nct_id>NCT03431740</nct_id>
  </id_info>
  <brief_title>FENO, Extended NO Analysis and NO/CO Diffusing Capacity in Thoracic Radiation Therapy</brief_title>
  <official_title>Fractional Exhaled NO, Extended NO Analysis and NO/CO Diffusing Capacity in Patients Receiving Thoracic Radiation Therapy: a Single Centre Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to investigate the impact of thoracic radiation therapy on diffusion&#xD;
      capacity of the lung (primary endpoint: diffusion capacity for nitric oxide, DLNO) and on&#xD;
      exhaled nitric oxide.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Insufficient recruitment&#xD;
  </why_stopped>
  <start_date type="Actual">February 15, 2018</start_date>
  <completion_date type="Actual">April 1, 2021</completion_date>
  <primary_completion_date type="Actual">April 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in diffusing capacity for nitric oxide (DLNO)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diffusing capacity for carbon monoxide (DLCO)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfer Coefficient for nitric oxide (DLNO/VA)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfer Coefficient for carbon monoxide (DLCO/VA)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of DLNO and DLCO</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alveolar-capillary membrane-diffusing capacity for carbon monoxide (DMCO)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulmonary capillary blood volume (Vc)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>This variable is a calculated variable. The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alveolar Volume (VA)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>This variable is a calculated variable. The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fractional concentration of exhaled nitric oxide at a flow rate of 50mL/s (FENO50)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concentration of nitric oxide in the gas phase of the alveolar or acinar region (CANO)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tissue concentration of nitric oxide of the airway wall (CawNO)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Airway compartment diffusing capacity of nitric oxide from the of of the airway wall to the gas stream (DawNO)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total flux of nitric oxide in the conducting airway compartment (JawNO)</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced expiratory volume in 1 second</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced vital capacity</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced expiratory flow between 25% and 75% of forced vital capacity</measure>
    <time_frame>Before start of radiation therapy (RT), at the day of end of RT, 6 weeks and 12 months after end of RT</time_frame>
    <description>The course over time will be described.</description>
  </secondary_outcome>
  <enrollment type="Actual">3</enrollment>
  <condition>Radiotherapy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population consists in patients with planned but not already commenced radiation&#xD;
        therapy of the chest. Recruitment will be performed at the Radiation Oncology Clinic at&#xD;
        University Hospital of Zurich.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  planned but not already commenced radiation therapy (RT) of the chest, with or without&#xD;
             pre-RT surgery.&#xD;
&#xD;
          -  signed informed consent of the participant&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  thoracic RT in the past&#xD;
&#xD;
          -  treatment with immune checkpoint inhibitors&#xD;
&#xD;
          -  unstable condition affecting participation in the measurements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital of Zurich</name>
      <address>
        <city>ZÃ¼rich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 18, 2018</study_first_submitted>
  <study_first_submitted_qc>February 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2018</study_first_posted>
  <last_update_submitted>April 16, 2021</last_update_submitted>
  <last_update_submitted_qc>April 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

